NasdaqCM - Nasdaq Real Time Price USD

TC Biopharm (Holdings) Plc (TCBPW)

Compare
0.0147 +0.0057 (+63.33%)
At close: December 13 at 4:00:00 PM EST
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
3,844.5320
1,978.6590
1,978.6590
Operating Expense
11,972.7600
14,239.3230
15,928.5290
9,259.3020
8,317.4700
Operating Income
-11,972.7600
-14,239.3230
-12,083.9970
-7,280.6430
-6,338.8110
Net Non Operating Interest Income Expense
--
-83.0250
-6,753.2310
-3,438.5150
-291.0330
Other Income Expense
-122.8080
7,326.6660
15,803.6270
-4,264.3090
--
Pretax Income
-12,178.5930
-6,995.6820
-3,033.6010
-14,983.4670
-6,629.8440
Tax Provision
-605.2570
-1,088.7290
-1,720.0000
-1,407.5420
-1,171.9280
Net Income Common Stockholders
-11,573.3360
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Diluted NI Available to Com Stockholders
-11,573.3360
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Total Operating Income as Reported
-11,972.7600
-14,239.3230
-12,083.9970
--
--
Total Expenses
11,972.7600
14,239.3230
15,928.5290
9,259.3020
8,317.4700
Net Income from Continuing & Discontinued Operation
-11,573.3360
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Normalized Income
-11,352.8594
-12,093.3794
-14,114.5389
-9,712.2038
-5,457.9160
Interest Income
--
--
2.2080
0.0330
1.0290
Interest Expense
--
83.0250
6,753.2310
3,438.5480
292.0620
Net Interest Income
--
-83.0250
-6,753.2310
-3,438.5150
-291.0330
EBIT
-4,646.0940
-6,912.6570
3,719.6300
-11,544.9190
-6,337.7820
EBITDA
-4,106.9810
-6,279.6490
4,489.2260
-10,519.8610
-5,262.5670
Reconciled Depreciation
539.1130
633.0080
769.5960
1,025.0580
1,075.2150
Net Income from Continuing Operation Net Minority Interest
-11,573.3360
-5,906.9530
-1,313.6010
-13,575.9250
-5,457.9160
Total Unusual Items Excluding Goodwill
-232.0070
7,326.6660
15,803.6270
-4,264.3090
--
Total Unusual Items
-232.0070
7,326.6660
15,803.6270
-4,264.3090
--
Normalized EBITDA
-3,874.9740
-13,606.3150
-11,314.4010
-6,255.5520
-5,262.5670
Tax Rate for Calcs
0.0000
0.0002
0.0002
0.0001
0.0002
Tax Effect of Unusual Items
-11.5304
1,140.2396
3,002.6891
-400.5878
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PTIXW Protagenic Therapeutics, Inc.
0.0140
0.00%
 
ATNFW 180 Life Sciences Corp.
0.0082
-8.89%
 
TVGNW Tevogen Bio Holdings Inc.
0.0420
-1.87%
 
NAMSW NewAmsterdam Pharma Company N.V.
13.02
-2.84%
 
UPB Upstream Bio, Inc.
20.25
-0.78%
 
CDIOW Cardio Diagnostics Holdings, Inc.
0.1050
+11.58%
 
ARMP Armata Pharmaceuticals, Inc.
2.1918
+4.37%
 
CEROW CERo Therapeutics Holdings, Inc.
0.0120
+0.84%
 
PTIX Protagenic Therapeutics, Inc.
0.4950
-3.15%
 
ALMS Alumis Inc.
8.39
-3.89%